Patents Represented by Attorney William B. Scasnlon

Find this attorney in the Justia Lawyer Directory

  • Process for preparing deacetylcephalosporin C
    Patent number: 5082772
    Abstract: Deacetoxycephalosporin C synthase obtained from cell-free extracts of Streptomyces clavuligerus was purified to near homogeneity and characterized in inactive form. The amino acid sequence was determined and the synthase recombinantly reproduced in active form in E. coli. The recombinantly produced synthase is provided in about 97% pure form by a chromatographic process. The synthase lacks DAOC hydroxylase function; however, it possesses the ability to transform 3-exomethylenocephalosporin C to deacetylcephalosporin C.
    Type: Grant
    Filed: October 24, 1988
    Date of Patent: January 21, 1992
    Assignee: Eli Lilly and Company
    Inventors: Joe E. Dotzlaf, Wu-Kuang Yeh